Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma

Por Wang, Jia-hong, Wei, Wei, Guo, Zhi-xing, Shi, Ming, Guo, Rong-ping
Publicado no J Transl Med (2015)

MicroRNA-200a inhibits epithelial-mesenchymal transition in human hepatocellular carcinoma cell line

Por Zhong, Chong, Li, Ming-Yi, Chen, Zhi-Yuan, Cheng, Hai-Kun, Hu, Ming-Li, Ruan, Yue-Lu, Guo, Rong-Ping
Publicado no Int J Clin Exp Pathol (2015)

Comparison of hepatic resection and transarterial chemoembolization for UICC stage T3 hepatocellular carcinoma: a propensity score matching study

Por Zhong, Chong, Zhang, Yong-Fa, Huang, Jun-Hai, Xiong, Cheng-Ming, Wang, Zi-Yu, Chen, Qing-Lian, Guo, Rong-Ping
Publicado no BMC Cancer (2018)

Intermediate-stage hepatocellular carcinoma treated with hepatic resection: the NSP score as an aid to decision-making

Por Zhang, Yong-Fa, Zhou, Jie, Wei, Wei, Zou, Ru-Hai, Chen, Min-Shan, Lau, Wan Yee, Shi, Ming, Guo, Rong-Ping
Publicado no Br J Cancer (2016)

Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study

Por He, Min-Ke, Le, Yong, Li, Qi-Jiong, Yu, Zi-Shan, Li, Shao-Hua, Wei, Wei, Guo, Rong-Ping, Shi, Ming
Publicado no Chin J Cancer (2017)

Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China

Por Shi, Ming, Chen, Ji-An, Lin, Xiao-Jun, Guo, Rong-Ping, Yuan, Yun-Fei, Chen, Min-Shan, Zhang, Ya-Qi, Li, Jin-Qing
Publicado em 2010

A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection

Por XIAO, CHENG-ZUO, WEI, WEI, GUO, ZHI-XING, LI, SHU-HONG, ZHANG, YONG-FA, WANG, JIA-HONG, SHI, MING, GUO, RONG-PING
Publicado no Oncol Lett (2015)

Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis

Por Li, Shao-Hua, Wang, Qiao-Xuan, Yang, Zhong-Yuan, Jiang, Wu, Li, Cong, Sun, Peng, Wei, Wei, Shi, Ming, Guo, Rong-Ping
Publicado no World J Gastroenterol (2017)

ELTD1 Function in Hepatocellular Carcinoma is Carcinoma-Associated Fibroblast-Dependent

Por Kan, Anna, Le, Yong, Zhang, Yong-fa, Duan, Fang-ting, Zhong, Xiao-ping, Lu, Liang-he, Ling, Yi-hong, Guo, Rong-ping
Publicado no J Cancer (2018)

A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma

Por Chen, Min-Shan, Li, Jin-Qing, Zheng, Yun, Guo, Rong-Ping, Liang, Hui-Hong, Zhang, Ya-Qi, Lin, Xiao-Jun, Lau, Wan Y.
Publicado em 2006

Partial Hepatectomy With Wide Versus Narrow Resection Margin for Solitary Hepatocellular Carcinoma: A Prospective Randomized Trial

Por Shi, Ming, Guo, Rong-Ping, Lin, Xiao-Jun, Zhang, Ya-Qi, Chen, Min-Shan, Zhang, Chang-Qing, Lau, Wan Yee, Li, Jin-Qing
Publicado em 2007

Transarterial chemoembolization combined with sorafenib for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus

Por Zhang, Yong-Fa, Wei, Wei, Wang, Jia-Hong, Xu, Li, Jian, Pei-En, Xiao, Cheng-Zuo, Zhong, Xiao-Ping, Shi, Ming, Guo, Rong-Ping
Publicado no Onco Targets Ther (2016)

Dovitinib preferentially targets endothelial cells rather than cancer cells for the inhibition of hepatocellular carcinoma growth and metastasis

Por Chen Zhi-Yuan, Shi Ming, Peng Li-Xia, Wei Wei, Li Xin-Jian, Guo Zhi-Xing, Li Shu-Hong, Zhong Chong, Qian Chao-Nan, Guo Rong-Ping
Publicado em 2012-12-01

Dovitinib preferentially targets endothelial cells rather than cancer cells for the inhibition of hepatocellular carcinoma growth and metastasis

Por Chen, Zhi-Yuan, Shi, Ming, Peng, Li-Xia, Wei, Wei, Li, Xin-Jian, Guo, Zhi-Xing, Li, Shu-Hong, Zhong, Chong, Qian, Chao-Nan, Guo, Rong-Ping
Publicado em 2012

Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma

Por Wang, Jia-hong, Wei, Wei, Xu, Jing, Guo, Zhi-xing, Xiao, Cheng-zuo, Zhang, Yong-fa, Jian, Pei-en, Wu, Xiao-liang, Shi, Ming, Guo, Rong-ping
Publicado no Oncotarget (2015)

Optimal surgical strategy for hepatocellular carcinoma with portal vein tumor thrombus: A propensity score analysis

Por Zhang, Yong-Fa, Le, Yong, Wei, Wei, Zou, Ru-Hai, Wang, Jia-Hong, OuYang, Han-Yue, Xiao, Cheng-Zuo, Zhong, Xiao-Ping, Shi, Ming, Guo, Rong-Ping
Publicado no Oncotarget (2016)

The Chinese medicine, Jianpi Huayu Decoction, inhibits the epithelial mesenchymal transition via the regulation of the Smad3/Smad7 cascade

Por Zhong, Chong, Zhang, Yong-Fa, Huang, Jun-Hai, Wang, Zi-Yu, Chen, Qiu-Yuan, Su, Li-Tian, Liu, Zhen-Tao, Xiong, Cheng-Ming, Tao, Zhi, Guo, Rong-Ping
Publicado no Am J Transl Res (2017)

Impact of oral anti–hepatitis B therapy on the survival of patients with hepatocellular carcinoma initially treated with chemoembolization

Por Zhou, Zhong-Guo, Zheng, Xing-Rong, Zhou, Qian, Shi, Ming, Zhang, Yao-Jun, Guo, Rong-Ping, Yuan, Yun-Fei, Chen, Min-Shan, Lin, Xiao-Jun, Lao, Xiang-Ming, Li, Sheng-Ping
Publicado no Chin J Cancer (2015)

Cezanne predicts progression and adjuvant TACE response in hepatocellular carcinoma

Por Wang, Jia-hong, Zhong, Xiao-ping, Zhang, Yong-fa, Wu, Xiao-liang, Li, Shao-hua, Jian, Pei-en, Ling, Yi-hong, Shi, Ming, Chen, Min-shan, Wei, Wei, Guo, Rong-ping
Publicado no Cell Death Dis (2017)